Results of studies with positron emission tomography (PET) of 18F-2-fluoro-2-deoxy-D-glucose (FDG) in patients with probable Alzheimer's disease (AD) were compared among three European centers with different PET scanners (in-plane resolution ranging between 6.75 mm and 9.2 mm). A ratio of glucose metabolism in the most typically affected regions over the least typically affected regions was calculated to quantitatively analyze the characteristic pattern of AD. Diagnostic accuracy of this composite ratio was high (95.8%) and was superior to that of most ratios derived from single regions. Correspondingly, there was a consistent, highly significant difference between patients (mean ratio 0.77 +/- 0.11) and normals (mean 0.99 +/- 0.04) without significant differences among laboratories. Possible small effects of rate constant variation and region size were analyzed by computer simulation. The results demonstrate that a common investigation protocol may yield FDG PET data in different laboratories that are closely comparable in spite of differences between scanners and imaging equipment

Herholz, K., Perani, D., Salmon, E., Franck, G., Fazio, F., Heiss, W., et al. (1993). Comparability of FDG PET studies in probable Alzheimer's disease. THE JOURNAL OF NUCLEAR MEDICINE, 34(9), 1460-1466.

Comparability of FDG PET studies in probable Alzheimer's disease

Fazio, F;
1993

Abstract

Results of studies with positron emission tomography (PET) of 18F-2-fluoro-2-deoxy-D-glucose (FDG) in patients with probable Alzheimer's disease (AD) were compared among three European centers with different PET scanners (in-plane resolution ranging between 6.75 mm and 9.2 mm). A ratio of glucose metabolism in the most typically affected regions over the least typically affected regions was calculated to quantitatively analyze the characteristic pattern of AD. Diagnostic accuracy of this composite ratio was high (95.8%) and was superior to that of most ratios derived from single regions. Correspondingly, there was a consistent, highly significant difference between patients (mean ratio 0.77 +/- 0.11) and normals (mean 0.99 +/- 0.04) without significant differences among laboratories. Possible small effects of rate constant variation and region size were analyzed by computer simulation. The results demonstrate that a common investigation protocol may yield FDG PET data in different laboratories that are closely comparable in spite of differences between scanners and imaging equipment
Articolo in rivista - Articolo scientifico
Sensitivity and Specificity; ROC Curve; Reproducibility of Results; Fluorodeoxyglucose F18; Humans; Alzheimer Disease; Brain; Aged; Fluorine Radioisotopes; Tomography, Emission-Computed; Deoxyglucose; Middle Aged; Female; Male
English
1993
34
9
1460
1466
none
Herholz, K., Perani, D., Salmon, E., Franck, G., Fazio, F., Heiss, W., et al. (1993). Comparability of FDG PET studies in probable Alzheimer's disease. THE JOURNAL OF NUCLEAR MEDICINE, 34(9), 1460-1466.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/35226
Citazioni
  • Scopus 80
  • ???jsp.display-item.citation.isi??? 72
Social impact